FARLETUZUMAB: 31 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
31
Total FAERS Reports
0
Deaths Reported
19
Hospitalizations
31
As Primary/Secondary Suspect
First Report: 20110628 · Latest Report: 201809
What Are the Most Common FARLETUZUMAB Side Effects?
#1 Most Reported
Thrombocytopenia
15 reports (48.4%)
#2 Most Reported
Febrile neutropenia
7 reports (22.6%)
#3 Most Reported
Anaemia
7 reports (22.6%)
All FARLETUZUMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Thrombocytopenia | 15 | 48.4% | 0 | 13 |
| Anaemia | 7 | 22.6% | 0 | 6 |
| Febrile neutropenia | 7 | 22.6% | 0 | 6 |
| Anal haemorrhage | 6 | 19.4% | 0 | 6 |
| Anal incontinence | 6 | 19.4% | 0 | 6 |
| Frequent bowel movements | 6 | 19.4% | 0 | 6 |
| White blood cell count decreased | 6 | 19.4% | 0 | 6 |
| Acute kidney injury | 5 | 16.1% | 0 | 5 |
| Hyperkalaemia | 5 | 16.1% | 0 | 5 |
| Small intestinal obstruction | 5 | 16.1% | 0 | 2 |
| Urinary tract infection | 5 | 16.1% | 0 | 5 |
Who Reports FARLETUZUMAB Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 63.8 years. Most reports from: BE. View detailed demographics →
Is FARLETUZUMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 11 | 0 | 11 |
What Is FARLETUZUMAB Used For?
| Indication | Reports |
|---|---|
| Ovarian cancer | 21 |
Official FDA Label for FARLETUZUMAB
Official prescribing information from the FDA-approved drug label.